Average Co-Inventor Count = 7.41
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
2. Dana-farber-cancer Institute Inc. (2 from 1,209 patents)
3. Colorado State University Research Foundation (2 from 470 patents)
4. University of Notre Dame Du Lac (2 from 368 patents)
17 patents:
1. 12365674 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
2. 12331044 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
3. 12331018 - Pyrrolidine orexin receptor agonists
4. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists
5. 12264134 - Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
6. 12152019 - Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors
7. 12091405 - Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors
8. 11992489 - Substituted tetrahydroquinoline compounds as indoleamine 2,3-dioxygenase inhibitors
9. 11976069 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
10. 11680060 - Bicycloheptane pyrrolidine orexin receptor agonists
11. 11478461 - [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
12. 11352320 - Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
13. 11098029 - 5-alkyl pyrrolidine orexin receptor agonists
14. 10945771 - Azabicyclo[4.1.0]heptane allosteric modulators of the M4 muscarinic acetylcholine receptor
15. 10927086 - Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors